Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)

NCT02395172 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

792

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Avelumab
DRUG: Docetaxel

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]